# Tesseract Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tesseract-health

- Industry: Healthcare
- Headquarters: New York, US
- Website: www.tesseracthealth.com
- Total disclosed funding: $80M
- Latest round: Series B (Apr 20, 2021)
- Investors on record: 3

## About

Tesseract Health Inc. is a US-based company specializing in advanced retinal imaging technology, improving healthcare diagnostics through innovative solutions for better patient outcomes.Founded in 2018 in New York, Tesseract Health Inc. focuses on the development of retinal imaging diagnostic technologies. The company raised USD 80 mn in Series B funding in April 2021, with investors including Foresite Capital and Glenview Capital Management. CEO Vasiliki Demas leads the firm, which has a history of advancing its imaging technology.Tesseract Health's core product, identifeye HEALTH, focuses on advanced retinal imaging through an automated platform designed to enhance healthcare diagnostics. By providing high-quality fundus image capture capabilities, the company aims to offer critical health insights at the point-of-care, facilitating early detection and monitoring of medical conditions, especially in North America and Europe.The revenue model for identifeye HEALTH is based on its imaging platform and future AI-powered tools, marketed primarily through business-to-business transactions with healthcare institutions. While specific pricing details are not disclosed, revenue is generated through direct sales agreements and partnerships as they work towards transforming diagnostic capabilities in healthcare settings.Following its recent USD 80 mn Series B funding on April 20, 2021, Tesseract Health Inc. plans to advance its Tesseract iC™ eye-imaging diagnostic technology platform and enhance its AI capabilities in preparation for commercial launch. This funding will support the development of new products while the company seeks expansion into additional markets, continuing to establish its presence in North America and Europe.

## Funding rounds

- Series B, Apr 20, 2021, $80M — Foresite Capital, Glenview Capital Management, Opaleye Management

## Investors

- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series B
- Glenview Capital Management — Series B
- Opaleye Management — Series B